No difference in mRNA expression level of CD226 on PBMCs was observed between the two groups (Supplementary Fig. 1A), whereas the expression of CD226 mRNA of allergen-challenged CD4+ cells and Th2 cells was significantly higher in patients with asthma (Supplementary Fig. 1B, C), further confirmed the above FCM results. This evidence concerns the gene CD226 and asthma.